EU Pharmaceutical reform: Factsheet – Access to medicines in all Member States

21/05/2024

The EU’s pharmaceutical reform aims to ensure access to medicines for all patients in the EU. Companies that provide access to their medicines in all Member States where their marketing authorisation is valid will be rewarded with two extra years of data protection.

Read the news announcement published by EC Directorate-General for Health and Food Safety on 11 March 2024.

lsgilbert

Voir tous les articles

---

OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (21 mai 2024). EU Pharmaceutical reform: Factsheet – Access to medicines in all Member States. ELSIBI. Consulté le 11 octobre 2026 à l’adresse https://doi.org/10.58079/11ow1

---

Étiquettes : EUEuropean CommissionPatient accessPharmaceutical legislation

• Article suivant EU Pharmaceutical Reform: Factsheet – Incentives to steer innovation and achieve public health objectives
• Article précédent Pharmaceutical reform: Factsheet – Steering innovation to address unmet medical needs

Vous aimerez aussi...

• 0

  Progressive roll-out of the In Vitro Diagnostic Medical Devices Regulation

  14/03/2022

   par lsgilbert

   par lsgilbert · Published 14/03/2022

• 0

  Reports confirm the European Health Union is better prepared to combat health threats

  13/02/2024

   par lsgilbert

   par lsgilbert · Published 13/02/2024

• 0

  EMA – PMS – Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Updates of the EU Implementation Guide

  04/10/2024

   par vroby

   par vroby · Published 04/10/2024